DFE Pharma is a global leader in pharmaceutical excipient solutions. Our portfolio of high‑purity, low‑endotoxin excipients (including BioHale® Sucrose and BioHale® Trehalose Dihydrate) stabilize biologics for parenteral, ophthalmic, and inhalation applications. We are committed to delivering uncompromised quality, reliable security of supply, and expert technical support to our partners worldwide.